News | September 21, 2009

GE Highlights Innovations in Molecular Imaging at WMIC

Discovery PET/CT 690

September 21, 2009 - GE Healthcare hosts two consortium workshops on imaging technologies and molecular imaging agents at the World Molecular Imaging Congress (WMIC) September 23-26, 2009, in Montreal, Canada.

At the GE Healthcare WMIC booth #302, the company will introduce new diagnostic imaging applications, GE Healthcare’s pre-clinical imaging serves the development of new therapeutics and tracers by using newest imaging technologies with animal disease models. The eXplore speCZT, the first full-ring solid-state detector small animal SPECT, focuses on high throughput and rapid dynamic imaging. The system utilizes a cadmium zinc telluride (CZT) detector with high-energy resolution to enable dual or triple radionuclide imaging. The system also has the capability to combine with the world-class CT120 X-ray CT system for seamless dual-modality imaging, and fusion. In this configuration, users can benefit from improved quantitative accuracy in measuring SPECT tracer uptake with our new SPECT/CT Attenuation Correction feature.

Understanding researcher’s multi-modality needs, the Triumph pre-clinical system, is an all digital, fully integrated molecular imaging system for biomedical research and pharmaceutical development, designed to accommodate any combination of SPECT, PET and CT.

Molecular imaging is only possible with the latest in imaging agents and radiopharmaceuticals. TRACERlab FX synthesizers are designed for the production these PET tracers. Worldwide researchers use TRACERlabs for the synthesis of common tracers and the rapid development of new PET imaging agents. GE Healthcare aims to simplify the complexity of radiopharmacy infrastructure into a single touch-point solution. TRACERcenter-GMP is a combination of equipment, information and services that allow you to establish and operate your research or clinical PET tracer production center with confidence by providing state-of-the-art instrumentation, comprehensive documentation and GMP training and consulting services to provide new centers with support and knowledge for the production of PET tracers.

The Discovery PET/CT 600 series continues to expand with the introduction of the Discovery PET/CT 690 – a molecular imaging tool designed go beyond the needs of the clinical practice and provide the necessary tools and technologies to explore the future of PET/CT imaging. With specialized detector configuration designed for sensitivity, event throughput and efficiency, researchers and clinicians have the necessary speed in workflow, protocol flexibility and unique timing resolution technology to help forge new frontiers in clinical techniques, drug discovery and motion management.

The IN Cell Analyzer 2000 is a flexible cell imaging system for High Content Analysis with excellent image quality, speed and ease-of-use for all screening and research needs. The flexibility of the system enables scientists to perform a wide variety of previously challenging experiments with a single instrument: from investigative microscopy through to automated screening, and imaging of organelles, cells, tissues and whole organisms.

In addition, GE will host workshops at WMIC. These are the following:

Innovations in Pre-Clinical Molecular Imaging (Thursday, September 24th, 5:40pm – 7:10pm): Track the molecular progression of disease and response to therapeutics over time in small animals to accelerate research. This session will explore core emerging technologies and applications through GE Healthcare's small animal molecular imaging systems in the journey to understand disease, from the beginning.

Current Topics in PET Tracer Research (Friday, September 25th, 7:30am – 9:00am) To nderstanddisease, from the beginning, molecular imaging requires the convergence of imaging agents and equipment. In this session, researchers from the academic community and from GE Healthcare will present and discuss progress in development and validation of new PET tracers.

For more information:

Related Content

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Overlay Init